Inflammatory Response during Neoadjuvant Chemotherapy with Immune Checkpoint Inhibitors in a Patient with T3N1 Triple-Negative Breast Cancer: A Case Report
The patient's inflammatory and cystic tumor response is an unreported variant of the NAC response, suggesting the potential for further exploration into the mechanisms driving such responses and their implications for treatment strategies.
Authors
- Takashi Yamanaka (ORCID: https://orcid.org/0000-0003-0117-5710)
- Toshinari Yamashita (ORCID: https://orcid.org/0000-0002-6479-1660)
- Yayoi Yamamoto (ORCID: https://orcid.org/0000-0001-7924-3221)
- Mio Yasukawa
- Kyoko Goda
- Saori Fujiwara (ORCID: https://orcid.org/0000-0002-3531-577X)
- Emi Yoshioka
- Akari Takahashi
Institutions
- Kanagawa Prefectural Hospital Organization (JP)
- Kanagawa Cancer Center
Publication Details
- Journal
- Surgical Case Reports
- Published
- 2025-01-01
- DOI
- https://doi.org/10.70352/scrj.cr.25-0172
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00